Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transdiagnostic behavioral and sociodemographic influences on the cognitive-adaptive functioning gap in neurodivergent children.

Scientific reports·2026
Same author

Short Report: An Examination of Children's Autism Traits and Their Association With Family Experience.

Autism research : official journal of the International Society for Autism Research·2026
Same author

Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8<sup>+</sup> T cells.

Nature biomedical engineering·2026
Same author

Validation of an improved insect bite hypersensitivity severity score for allergic equine insect bite hypersensitivity in horses.

Journal of veterinary internal medicine·2026
Same author

Transition to adulthood in Duchenne Muscular Dystrophy: a systematic review with narrative synthesis on health systems, policies, and the role of health care providers.

Frontiers in public health·2026
Same author

Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.

Frontiers in allergy·2026

相关实验视频

Updated: Jun 30, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.9K

在实验室中制定mRNA-脂质纳米粒子疫苗的基本方法

Natalia T Jarzebska1,2, Julia Frei1,3, Mark Mellett1,3

  • 1Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.

Methods in molecular biology (Clifton, N.J.)
|May 30, 2024
PubMed
概括

脂质纳米颗粒 (LNP) 对于提供像mRNA疫苗这样的RNA疗法至关重要. 本指南详细介绍了一种简单的方法,用于制备有效的LNP封装的mRNA疫苗,从而提高治疗效果.

关键词:
传染病 传染病 传染病脂质纳米颗粒的使用方法消息传递者RNA是什么意思微流体混合的混合方式经过修改的核酸.伪尿素是一种假尿素.没有修改的核酸.疫苗 疫苗 疫苗 疫苗

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

相关实验视频

Last Updated: Jun 30, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.9K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.2K

科学领域:

  • 生物技术是生物技术.
  • 纳米医学是一种纳米医学.
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 包括siRNA和mRNA疫苗在内的RNA疗法已经显示出显著的临床成功.
  • 脂质纳米颗粒 (LNP) 对于保护RNA免受降解和促进细胞传递至关重要.
  • LNP-RNA系统的有效性取决于LNP合成方法和脂质组成.

研究的目的:

  • 为准备用LNP封装的mRNA疫苗提供详细和简单的方案.
  • 突出LNP合成和脂质组成对于治疗性RNA输送的重要性.

主要方法:

  • 详细的逐步指南LNP合成.
  • 专注于优化mRNA封装的脂质组成.
  • 用于制备LNP封装的mRNA疫苗的协议.

主要成果:

  • 一种简单可重复的方法来制备LNP.
  • 在LNP中成功封装mRNA的演示.
  • 建立一个开发有效LNP-mRNA疫苗配方的基础.

结论:

  • 简单的LNP制备方法对于推进RNA疗法至关重要.
  • 优化LNP合成和组成是成功提供mRNA疫苗的关键.
  • 本指南有助于开发和生产LNP封装的mRNA疫苗.